FDA NDC Directory · JSON-LD · Markdown

Theophylline

NDC 27241-273 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218401
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE ANHYDROUS (450 mg/1)
Marketing started20250113
Package count1

External sources

Source: openFDA. Public-domain (CC0).